Prevacid vs Lifestyle Modifications for the Treatment of LPR

NCT00274339 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

135

Enrollment

INDIV

Sponsor class

Conditions

Laryngopharyngeal Reflux

Interventions

DRUG: Prevacid 30mg BID
BEHAVIORAL: Lifestyle changes of exercise and diet changes for weight loss and avoidance of reflux inducing foods.

Sponsor

Hodge, Kenneth M., M.D.

Collaborators

[object Object]